These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23961576)

  • 21. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
    Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
    J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress ulcer prophylaxis in hospitalized patients not in intensive care units.
    Grube RR; May DB
    Am J Health Syst Pharm; 2007 Jul; 64(13):1396-400. PubMed ID: 17592004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopically proven stress ulceration.
    Devlin JW; Ben-Menachem T; Ulep SK; Peters MJ; Fogel RP; Zarowitz BJ
    Ann Pharmacother; 1998 Sep; 32(9):869-74. PubMed ID: 9762371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients admitted to Australian intensive care units: impact of remoteness and distance travelled on patient outcome.
    Flabouris A; Hart GK; Nicholls A
    Crit Care Resusc; 2012 Dec; 14(4):256-67. PubMed ID: 23230874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An observational study of changes to long-term medication after admission to an intensive care unit.
    Campbell AJ; Bloomfield R; Noble DW
    Anaesthesia; 2006 Nov; 61(11):1087-92. PubMed ID: 17042848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.
    Shin S
    Ther Clin Risk Manag; 2015; 11():649-57. PubMed ID: 26005351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate discharge on bronchodilators and acid-blocking medications after ICU admission: importance of medication reconciliation.
    Pavlov A; Muravyev R; Amoateng-Adjepong Y; Manthous CA
    Respir Care; 2014 Oct; 59(10):1524-9. PubMed ID: 24847095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress Ulcer Prophylaxis in Hospitalized Patients, Subsequent Use in Primary Care, and Physicians' Opinions About Acid-Suppressive Therapy.
    Riaz M; Hughes S; Gomez IA; Mortimer RB
    South Med J; 2016 Mar; 109(3):158-64. PubMed ID: 26954653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings.
    Qadeer MA; Richter JE; Brotman DJ
    J Hosp Med; 2006 Jan; 1(1):13-20. PubMed ID: 17219466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.
    Masood U; Sharma A; Bhatti Z; Carroll J; Bhardwaj A; Sivalingam D; Dhamoon AS
    Inquiry; 2018; 55():46958018759116. PubMed ID: 29502481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adequacy of stress ulcer prophylaxis prescription in the intensive care unit: an observational study.
    Franchitti M; Piubellini J; Sadeghipour F; Eckert P; Voirol P; Schneider AG
    Swiss Med Wkly; 2020 Aug; 150():w20322. PubMed ID: 32905610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary drug-use evaluation for stress ulcer prophylaxis.
    Hatton J
    Am J Hosp Pharm; 1992 Jun; 49(6):1440-4. PubMed ID: 1529986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis.
    Bateman AP; McArdle F; Walsh TS
    Crit Care Med; 2009 Jun; 37(6):1906-12. PubMed ID: 19384207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical therapy on the wards after early physical activity and mobility in the intensive care unit.
    Hopkins RO; Miller RR; Rodriguez L; Spuhler V; Thomsen GE
    Phys Ther; 2012 Dec; 92(12):1518-23. PubMed ID: 22491481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
    Redfern RE; Brown M; Karhoff KL; Middleton JL
    South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing readmissions to the intensive care unit.
    Russell S
    Heart Lung; 1999; 28(5):365-72. PubMed ID: 10486454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Neuroleptic Utilization in the Intensive Care Unit During Transitions of Care.
    Gilbert B; Morales JR; Searcy RJ; Johnson DW; Ferreira JA
    J Intensive Care Med; 2017 Feb; 32(2):158-162. PubMed ID: 28103769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to stress-related mucosal damage prophylaxis guideline in patients admitted to the Intensive Care Unit.
    Rafinazari N; Abbasi S; Farsaei S; Mansourian M; Adibi P
    J Res Pharm Pract; 2016; 5(3):186-92. PubMed ID: 27512710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.